TY - JOUR

T1 - From a problem to a business opportunity-design of pharmaceuticals for environmental biodegradability

AU - Kümmerer, Klaus

N1 - The author wants to thank the involved co-workers and the Deutsche Bundesstiftung Umwelt for supporting the work with GSF (Grant 22597-31 ) and the derivatives of ciprofloxacin (Grant 30839) and the Bundesministerium for Bildung und Forschung for supporting (Grant 03X9410 ) the work with the ß-blockers.

PY - 2019/6

Y1 - 2019/6

N2 - Research of the past 20 years has demonstrated that human and veterinary pharmaceuticals are present in the environment. In addition to the parent compounds also metabolites and other transformation products formed within treatment or in the environment have been detected. In order to overcome the shortcomings of effluent and manure treatment new active compounds were designed for complete mineralization in the environment.

AB - Research of the past 20 years has demonstrated that human and veterinary pharmaceuticals are present in the environment. In addition to the parent compounds also metabolites and other transformation products formed within treatment or in the environment have been detected. In order to overcome the shortcomings of effluent and manure treatment new active compounds were designed for complete mineralization in the environment.

KW - Sustainability Science

KW - Chemistry

KW - Pharmaceutical

KW - Enviroment

KW - Water

KW - Soil

KW - Chemoinformatic

KW - Sustainable development goal

KW - targeted design

UR - http://www.scopus.com/inward/record.url?scp=85062805316&partnerID=8YFLogxK

U2 - 10.1016/j.scp.2019.100136

DO - 10.1016/j.scp.2019.100136

M3 - Scientific review articles

VL - 12

JO - Sustainable Chemistry and Pharmacy

JF - Sustainable Chemistry and Pharmacy

SN - 2352-5541

M1 - 100136

ER -